Walgreens Boots Alliance Inc


Want a discount? Become a member by purchasing Annual Subscription!
SKU: WBA-2 Category:


Walgreens Boots Alliance surpassed Wall Street’s revenue and earnings expectations, showcasing resilience in a challenging US retail environment. Despite a fragile market and consumer pressures from inflation and decreased savings, first-quarter adjusted EPS stood at $0.66. This achievement reflects the adept execution and cost discipline in US Retail Pharmacy, sustained robust performance internationally, and progress in US Healthcare profitability initiatives. While encountering macroeconomic difficulties and acknowledging structural challenges, Walgreens’ management underscores the strategic moves in progress. Their unique advantage lies in their expansive local footprint and 85,000-strong workforce, fostering trusted community connections. The company’s commitment to meaningful patient interactions is further exemplified by initiatives like micro fulfillment centers, virtual pharmacy pilots, and collaborations with pharmacy schools. Looking ahead, their team aims to leverage its assets efficiently, expanding services like clinical trial offerings and advancing gene and cell therapy initiatives. They further launched a brand-new Rx Savings Finder, an easy-to-use online resource meant to assist consumers in saving money on prescription drugs. This launch will ease the burden of its pharmacists by streamlining the search process across several discount card websites.

Our Report Structure:

⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures

Want unlimited access to our reports? Purchase our $99 annual subscription!